Growth Metrics

Genoil (GNOLF) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Genoil (GNOLF) over the last 7 years, with Q3 2025 value amounting to $12036.0.

  • Genoil's Cash & Equivalents rose 1502.29% to $12036.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $12036.0, marking a year-over-year increase of 1502.29%. This contributed to the annual value of $12036.0 for FY2024, which is 13862.01% up from last year.
  • According to the latest figures from Q3 2025, Genoil's Cash & Equivalents is $12036.0, which was up 1502.29% from $12036.0 recorded in Q2 2025.
  • Genoil's 5-year Cash & Equivalents high stood at $35200.0 for Q3 2022, and its period low was $0.03 during Q2 2022.
  • Its 5-year average for Cash & Equivalents is $9149.6, with a median of $5055.0 in 2021.
  • Per our database at Business Quant, Genoil's Cash & Equivalents crashed by 9999.95% in 2022 and then skyrocketed by 1814900765.69% in 2023.
  • Quarter analysis of 5 years shows Genoil's Cash & Equivalents stood at $12.0 in 2021, then soared by 41933.33% to $5044.0 in 2022, then skyrocketed by 107.45% to $10464.0 in 2023, then increased by 15.02% to $12036.0 in 2024, then changed by 0.0% to $12036.0 in 2025.
  • Its Cash & Equivalents was $12036.0 in Q3 2025, compared to $12036.0 in Q2 2025 and $12036.0 in Q1 2025.